CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival.

J Clin Med · 2022 · PMC9144978 · PMID 35629039

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0890

boldest claim

The sentences

a statistical trendp = 0.06so close (0.05 < p ≤ 0.1)

The first included the R-ISS and CD24, and showed that the latter did not retain its significance as an OS predictor ( p = 0.13), although there was a statistical trend towards significance when the R-ISS and CD24 PFS were assessed ( p = 0.06; HR = 0.984 with a CI of 0.967–1.001).

also in 2,798 other papers

showed a trendp = 0.089so close (0.05 < p ≤ 0.1)

However, CD24 levels >5% showed a trend towards a better OS ( p = 0.089).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.